These data demonstrate that enhanced levels of ANKRD49 expression are closely associated with advanced stages of LUAD development, including TNM stage III and IV, lymph node metastasis, distant metastasis, and differentiation of the tumour, but not sex, age, histological grade, or tumour size. This evidence concerns the gene ANKRD49 and metastatic malignant neoplasm in the lymph nodes.